Breadcrumb Home News Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session Wednesday, March 29, 2023 Perspective Therapeutics https://perspectivetherapeutics.com/initial-results-from-first-patient-dosed-wi…